Ryr2tm3.1Amks
Targeted Allele Detail
|
Symbol: |
Ryr2tm3.1Amks |
Name: |
ryanodine receptor 2, cardiac; targeted mutation 3.1, Andrew R Marks |
MGI ID: |
MGI:5582510 |
Synonyms: |
RyR2-N2386I |
Gene: |
Ryr2 Location: Chr13:11567988-12121831 bp, - strand Genetic Position: Chr13, 4.38 cM, cytoband A1-A2
|
Alliance: |
Ryr2tm3.1Amks page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:212640
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: Exon 47 was replaced with a self-excising neomycin resistance cassette and a modified exon 47 in which nucleotide substitution(s) results(s) in the amino acid susbtitution of isoleucine for asparagine at position 2386 (N2386I), mimicking a mutation found in some catecholaminergic polymorphic ventricular tachycardia (CPVT) patients. This mutation results in a leaky channel. The final allele lacks the selection cassette.
(J:212640)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Ryr2 Mutation: |
325 strains or lines available
|
|
Original: |
J:212640 Shan J, et al., Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2012 Aug 31;111(6):708-17 |
All: |
1 reference(s) |
|